应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
DPRX Dipexium Pharmaceuticals, Inc.
退市 04-19 16:00:00 EDT
1.34
+0.04
+2.92%
最高
1.35
最低
1.25
成交量
14.43万
今开
1.30
昨收
1.30
日振幅
7.69%
总市值
1,489万
流通市值
685.06万
总股本
1,113万
成交额
19.30万
换手率
2.82%
流通股本
512.00万
市净率
0.82
ROE
--
每股收益
-2.07
52周最高
17.75
52周最低
1.05
市盈率
-0.65
股息
0.00
股息收益率
0.00
ROA
--
分时
五日
日K
周K
月K
暂无数据
北京优虎网络科技有限公司
资讯
新帖
简况
暂无数据
公司概况
公司名称:
Dipexium Pharmaceuticals, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Dipexium Pharmaceuticals, Inc.最初作为一个有限责任公司,于2010年1月14日公司在特拉华州的法律下成立。公司是一家较晚阶段制药公司专注于开发和商业化 Locilex (酸培西加南1%),一种新型、宽广的外用抗生素。Locilex是由隔绝的非洲爪蛙皮肤的22-氨基的氨基酸肽化学合成。其新型通过破坏细菌的细胞膜渗透性杀死微生物。Locilex 最初是被用来治疗糖尿病足溃疡的轻度感染。公司的主要目标是把Locilex 作为轻度DFI患者的治疗护理标准。此后,其增长战略包括为 Locilex扩大征兆,包括糖尿病足溃疡 (或适度 DFI) 的中度感染及某些其他轻度或中度的皮肤及皮肤结构感染的表面伤痕。
发行价格:
--
{"stockData":{"symbol":"DPRX","market":"US","secType":"STK","nameCN":"Dipexium Pharmaceuticals, Inc.","latestPrice":1.338,"timestamp":1492632000000,"preClose":1.3,"halted":4,"volume":144261,"delay":0,"floatShares":5120000,"shares":11129747,"eps":-2.07,"marketStatus":"退市","change":0.038,"latestTime":"04-19 16:00:00 EDT","open":1.3,"high":1.35,"low":1.25,"amount":193021.21800000002,"amplitude":0.076923,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.07,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1757491200000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":1.3,"volumeRatio":0},"requestUrl":"/m/hq/s/DPRX","defaultTab":"news","newsList":[],"profile":{"websiteUrl":"http://www.dipexiumpharmaceuticals.com","compareEarnings":[{"period":"1week","weight":0.0059},{"period":"1month","weight":0.0183},{"period":"3month","weight":0.0759},{"period":"6month","weight":0.161},{"period":"1year","weight":0.2007},{"period":"ytd","weight":0.1071}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Dipexium Pharmaceuticals, Inc.最初作为一个有限责任公司,于2010年1月14日公司在特拉华州的法律下成立。公司是一家较晚阶段制药公司专注于开发和商业化 Locilex (酸培西加南1%),一种新型、宽广的外用抗生素。Locilex是由隔绝的非洲爪蛙皮肤的22-氨基的氨基酸肽化学合成。其新型通过破坏细菌的细胞膜渗透性杀死微生物。Locilex 最初是被用来治疗糖尿病足溃疡的轻度感染。公司的主要目标是把Locilex 作为轻度DFI患者的治疗护理标准。此后,其增长战略包括为 Locilex扩大征兆,包括糖尿病足溃疡 (或适度 DFI) 的中度感染及某些其他轻度或中度的皮肤及皮肤结构感染的表面伤痕。","exchange":"NASDAQ","name":"Dipexium Pharmaceuticals, Inc.","nameEN":"Dipexium Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Dipexium Pharmaceuticals, Inc.(DPRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Dipexium Pharmaceuticals, Inc.(DPRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Dipexium Pharmaceuticals, Inc.,DPRX,Dipexium Pharmaceuticals, Inc.股票,Dipexium Pharmaceuticals, Inc.股票老虎,Dipexium Pharmaceuticals, Inc.股票老虎国际,Dipexium Pharmaceuticals, Inc.行情,Dipexium Pharmaceuticals, Inc.股票行情,Dipexium Pharmaceuticals, Inc.股价,Dipexium Pharmaceuticals, Inc.股市,Dipexium Pharmaceuticals, Inc.股票价格,Dipexium Pharmaceuticals, Inc.股票交易,Dipexium Pharmaceuticals, Inc.股票购买,Dipexium Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Dipexium Pharmaceuticals, Inc.(DPRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Dipexium Pharmaceuticals, Inc.(DPRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}